Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes.

Hill JM, Quenelle DC, Cardin RD, Vogel JL, Clement C, Bravo FJ, Foster TP, Bosch-Marce M, Raja P, Lee JS, Bernstein DI, Krause PR, Knipe DM, Kristie TM.

Sci Transl Med. 2014 Dec 3;6(265):265ra169. doi: 10.1126/scitranslmed.3010643.

PMID:
25473037
2.

Irises: A practical tool for image-based analysis of cellular DNA content.

Vogel JL, Michaelson D, Santella A, Hubbard EJ, Bao Z.

Worm. 2014 May 8;3:e29041. doi: 10.4161/worm.29041. eCollection 2014.

3.

Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging.

Americo JL, Sood CL, Cotter CA, Vogel JL, Kristie TM, Moss B, Earl PL.

Virology. 2014 Jan 20;449:120-32. doi: 10.1016/j.virol.2013.11.017. Epub 2013 Nov 28.

4.

Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity.

Rai G, Kawamura A, Tumber A, Liang Y, Vogel JL, Arbuckle JH, Rose NR, Dexheimer TS, Foley TL, King ON, Quinn A, Mott BT, Schofield CJ, Oppermann U, Jadhav A, Simeonov A, Kristie TM, Maloney DJ.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Dec 17 [updated 2013 Sep 16].

5.

The dynamics of HCF-1 modulation of herpes simplex virus chromatin during initiation of infection.

Vogel JL, Kristie TM.

Viruses. 2013 May 22;5(5):1272-91. doi: 10.3390/v5051272. Review.

6.

A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.

Liang Y, Quenelle D, Vogel JL, Mascaro C, Ortega A, Kristie TM.

MBio. 2013 Feb 5;4(1):e00558-12. doi: 10.1128/mBio.00558-12.

7.

Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency.

Liang Y, Vogel JL, Arbuckle JH, Rai G, Jadhav A, Simeonov A, Maloney DJ, Kristie TM.

Sci Transl Med. 2013 Jan 9;5(167):167ra5. doi: 10.1126/scitranslmed.3005145.

8.

Supportive breeding boosts natural population abundance with minimal negative impacts on fitness of a wild population of Chinook salmon.

Hess MA, Rabe CD, Vogel JL, Stephenson JJ, Nelson DD, Narum SR.

Mol Ecol. 2012 Nov;21(21):5236-50. doi: 10.1111/mec.12046. Epub 2012 Oct 1.

9.

Crosstalk between O-GlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway.

Daou S, Mashtalir N, Hammond-Martel I, Pak H, Yu H, Sui G, Vogel JL, Kristie TM, Affar el B.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2747-52. doi: 10.1073/pnas.1013822108. Epub 2011 Feb 1.

10.

The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias.

Mazars R, Gonzalez-de-Peredo A, Cayrol C, Lavigne AC, Vogel JL, Ortega N, Lacroix C, Gautier V, Huet G, Ray A, Monsarrat B, Kristie TM, Girard JP.

J Biol Chem. 2010 Apr 30;285(18):13364-71. doi: 10.1074/jbc.M109.072579. Epub 2010 Mar 3.

11.

Transcriptional coactivator HCF-1 couples the histone chaperone Asf1b to HSV-1 DNA replication components.

Peng H, Nogueira ML, Vogel JL, Kristie TM.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2461-6. doi: 10.1073/pnas.0911128107. Epub 2010 Jan 21.

12.

Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM.

Nat Med. 2009 Nov;15(11):1312-7. doi: 10.1038/nm.2051. Epub 2009 Oct 25.

13.

Control of alpha-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities.

Kristie TM, Liang Y, Vogel JL.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):257-65. doi: 10.1016/j.bbagrm.2009.08.003. Epub 2009 Aug 12. Review.

14.

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC.

Nutr Metab (Lond). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31.

15.

Hypometabolism as a therapeutic target in Alzheimer's disease.

Costantini LC, Barr LJ, Vogel JL, Henderson ST.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S16. doi: 10.1186/1471-2202-9-S2-S16. Review.

16.

Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interaction with protein cofactors.

Vogel JL, Kristie TM.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):6817-22. Epub 2006 Apr 19.

19.
20.

C-terminal deletions can suppress temperature-sensitive mutations and change dominance in the phage Mu repressor.

Vogel JL, Geuskens V, Desmet L, Higgins NP, Toussaint A.

Genetics. 1996 Mar;142(3):661-72.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk